Testosterone Replacement Therapy Market In-Depth Analysis & Forecast 2019-2027



Testosterone Replacement Therapy (TRT) or low testosterone therapy is a type of hormone therapy for men that is used to treat the effects of decreased gonad activity, also known as hypogonadism. Hypogonadism in men is a clinical syndrome caused by the testes' inability to produce physiological levels of Testosterone Replacement Therapy Market. Hypogonadism can be primary (caused by a problem with the testes), secondary (caused by a problem with the hypothalamus or pituitary gland), or combined (caused by both). Primary hypogonadism is caused by genetic abnormalities, testicular trauma, orchitis, radiation treatment, or chemotherapy, whereas secondary hypogonadism is caused by the pituitary and hypothalamic genetic abnormalities.

Furthermore, severe psychological or emotional stress, obesity (WHO grade III or IV- BMI > 30), nutritional deficiency or eating disorders, untreated obstructive sleep apnea, medication such as opioids, androgens, glucocorticoids, anabolic steroids; chronic systemic illness caused by kidney, lung, heart failure, diabetes mellitus, HIV infection, Crohn's disease, and ageing are all functional causes of hypogonadism. Testosterone Replacement Therapy Market is a promising technology for treating hypogonadism symptoms and increasing testosterone levels. Furthermore, the use of testosterone replacement therapy has been linked to an increase in muscle tissue, an increase in overall body energy, and a significant decrease in depression symptoms.

Drivers of the Testosterone Replacement Therapy Market

Hypogonadism in men is characterised primarily by a decrease in serum Testosterone Replacement Therapy Market concentration, which results in decreased libido, erectile dysfunction, loss of body and facial hair, decreased bone density, weakness, decreased lean body mass, increased body fat, fatigue, and anaemia. Because hypogonadism men often ignore the symptoms or attribute them to alternate causes such as ageing, hypogonadism in adult men is frequently overlooked; even in the presence of associated symptoms.

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030